Prenatal RhD testing: A review of studies published from 2006 to 2008

Transfusion Medicine and Hemotherapy

Volumn 36, Issue 3, 2009, Pages 189-198

  Legler, Tobias Jörg ^a   Müller, Sina Patricia ^a   Haverkamp, Alexander ^a   Grill, Simon ^b   Hahn, Sinuhe ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

Author keywords

Fetal DNA; Maternal plasma; SAFE

Indexed keywords

RHESUS D ANTIBODY;

BLOOD ANALYSIS; BLOOD GROUP RHESUS SYSTEM; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA EXTRACTION; DNA SEQUENCE; FUNDING; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; MATERNAL BLOOD; MEDICAL INFORMATION; MEDICAL SOCIETY; PHYSICIAN; PRENATAL CARE; PRENATAL DIAGNOSIS; PROPHYLAXIS; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 67650263847     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000216580     Document Type: Review

References (56)

1. Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE: Detection of fetal RhD-specific sequences in maternal plasma. Lancet 1998;352:1196.
2. Finning KM, Martin PG, Soothill PW, Avent ND: Prediction of fetal D status from maternal plasma: Introduction of a new noninvasive fetal RhD geno-typing service. Transfusion 2002;42:1079-1085.
3. Rijnders RJ, Christiaens GC, Bossers B, van der Smagt JJ, van der Schoot CE, de Haas M: Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol 2004;103:157-164.
4. Kumar S, Regan F: Management of pregnancies with RhD alloimmunisation. BMJ 2005;330:1255-1258.
5. van der Schoot CE, Hahn S, Chitty LS: Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008;13:63-68.
6. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738.
7. Daniels G: Blood group antibodies in haemolytic disease of the fetus and newborn; in Hadley A, Soothill P (eds): Alloimmune Disorders of Pregnancy. Cambridge: Cambridge University Press, 2002, pp 21-40.
8. Tabor A, Bang J, Norgaard-Pedersen B: Feto-ma-ternal haemorrhage associated with genetic amnio-centesis: Results of a randomized trial. Br J Obstet Gynaecol 1987;94:528-534.
9. Mujezinovic F, Alfirevic Z: Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110:687-694.
10. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado-Singh R, Berry S, Martinez-Poyer J, Blackwell SC: Noninvasive diagnosis by doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative group for doppler assessment of the blood velocity in anemic fetuses. N Engl J Med 2000;342:9-14.
11. Oepkes D, Seaward PG, Vandenbussche FP, Win-drim R, Kingdom J, Beyene J, Kanhai HH, Ohls-son A, Ryan G: Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006;355:156-164.
12. Dennis Lo YM: Fetal DNA in maternal plasma, progress through epigenetics. Ann N Y Acad Sci 2006;1075:74-80.
13. Flori E, Doray B, Gautier E, Kohler M, Ernault P, Flori J, Costa JM: Circulating cell-free fetal DNA in maternal serum appears to originate from cyto-and syncytio-trophoblastic cells. Case report. Hum Reprod 2004;19:723-724.
14. Zhong XY, Holzgreve W, Hahn S: Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythro-blasts. Mol Hum Reprod 2002;8:864-870.
15. Zhong XY, Holzgreve W, Tercanli S, Wenzel F, Hahn S: Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid. Arch Gyne-col Obstet 2006;273:221-226.
16. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, Lo KW, Huang DW, Lo YM: Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92.
17. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S: Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004;50:1002-1011.
18. Hahn S, Huppertz B, Holzgreve W: Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 2005;26:515-526.
19. Bischoff FZ, Lewis DE, Simpson JL: Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update 2005;11:59-67.
20. Gupta AK, Holzgreve W, Huppertz B, Malek A, Schneider H, Hahn S: Detection of fetal DNA and RNA in placenta-derived syncytiotropho-blast microparticles generated in vitro. Clin Chem 2004;50:2187-2190.
21. Zhong XY, Burk MR, Troeger C, Kang A, Holz-greve W, Hahn S: Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol 2000;96:991-996.
22. Rijnders RJ, Van Der Luijt RB, Peters ED, Goeree JK, Van Der Schoot CE, Ploos Van Amstel JK, Christiaens GC: Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 2003;23:1042-1044.
23. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-775.
24. Müller SP, Bartels I, Stein W, Emons G, Guten-sohn K, Köhler M, Legler TJ: The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008;48:2292-2301.
25. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM: Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-224.
26. Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, Bianchi DW: Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples. Clin Chem 2003;49:195-198.
27. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G: Effect of high throughput RhD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336: 816-818.
28. Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM: Routine fetal RhD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 2008;48:373-381.
29. Rouillac-Le Sciellour C, Puillandre P, Gillot R, Baulard C, Metral S, Le Van Kim C, Cartron JP, Colin Y, Brossard Y: Large-scale pre-diagnosis study of fetal RhD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004;8:23-31.
30. Geifman-Holtzman O, Grotegut CA, Gaughan JP: Diagnostic accuracy of noninvasive fetal Rh geno-typing from maternal blood - a meta-analysis. Am J Obstet Gynecol 2006;195:1163-1173.
31. Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M: Non-invasive antenatal RHD typing. Transfus Clin Biol 2006;13:53-57.
32. Clausen FB, Krog GR, Rieneck K, Dziegiel MH: Improvement in fetal DNA extraction from maternal plasma. Evaluation of the nuclisens magnetic extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. Prenat Diagn 2007;27:6-10.
33. Rouillac-Le Sciellour C, Serazin V, Brossard Y, Oudin O, Le Van Kim C, Colin Y, Guidicelli Y, Menu M, Cartron JP: Noninvasive fetal RhD geno-typing from maternal plasma. Use of a new developed free DNA fetal kit RhD. Transfus Clin Biol 2007;14:572-577.
34. Legler TJ, Liu Z, Mavrou A, Finning K, Hromad-nikova I, Galbiati S, Meaney C, Hulten MA, Crea F, Olsson ML, Maddocks DG, Huang D, Fisher SA, Sprenger-Haussels M, Soussan AA, van der Schoot CE: Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007;27:824-829.
35. Chitty LS, van der Schoot CE, Hahn S, Avent ND: SAFE - the special non-invasive advances in fetal and neonatal evaluation network: aims and achievements. Prenat Diagn 2008;28:83-88.
36. Grootkerk-Tax MG, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE: Evaluation of prenatal RhD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006; 46:2142-2148.
37. Kimura M, Sato C, Hara M, Ishihara O, Ikebuchi K: Noninvasive fetal RhD genotyping by maternal plasma with capillary electrophoresis. Transfusion 2008;48:1156-1163.
38. Al-Yatama MK, Mustafa AS, Al-Kandari FM, Khaja N, Zohra K, Monem RA, Abraham S: Polymerase-chain-reaction-based detection of fetal Rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy. Med Princ Pract 2007;16: 327-332.
39. Page-Christiaens GC, Bossers B, van der Schoot CE, de Haas M: Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal geno-typing in maternal blood: First clinical experience. Ann N Y Acad Sci 2006;1075:123-129.
40. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM: Hypermethylated Rassf1a in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-2218.
41. Tong YK, Chiu RW, Leung TY, Ding C, Lau TK, Leung TN, Lo YM: Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma. Clin Chem 2007;53:1906-1914.
42. Chow KC, Chiu RW, Tsui NB, Ding C, Lau TK, Leung TN, Lo YM: Mass spectrometric detection of an SNP panel as an internal positive control for fetal DNA analysis in maternal plasma. Clin Chem 2007;53:141-142.
43. Daniels G, van der Schoot CE, Olsson ML: Report of the first international workshop on molecular blood group genotyping. Vox Sang 2005;88:136-142.
44. Daniels G, van der Schoot CE, Olsson ML: Report of the second international workshop on molecular blood group genotyping. Vox Sang 2007;93:83-88.
45. Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die ärztliche Betreu-ung während der Schwangerschaft und nach der Entbindung ('Mutterschafts-Richtlinien'), Bun-desanzeiger 1986;60a, last update Bundesanzeiger 2008;95:2261.
46. Mayne S, Parker JH, Harden TA, Dodds SD, Beale JA: Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme. BMJ 1997;315:1588.
47. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P: Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995;345:1211-1213.
48. Kenny-Walsh E: Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999;340:1228-1233.
49. Dittmann S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt F: Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991;13:323-327.
50. Urbaniak SJ, Greiss MA: RhD haemolytic disease of the fetus and the newborn. Blood Rev 2000;14:44-61.
51. Denomme GA, Dake LR, Vilensky D, Ramyar L, Judd WJ: Rh discrepancies caused by variable reactivity of partial and weak d types with different serologic techniques. Transfusion 2008;48:473-478.
52. Flegel WA: How I manage donors and patients with a weak D phenotype. Curr Opin Hematol 2006;13:476-483.
53. Wagner FF, Kasulke D, Kerowgan M, Flegel WA: Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. In-fusionsther Transfusionsmed 1995;22:285-290.
54. Minon JM, Senterre JM, Schaaps JP, Foidart JM: An unusual false-positive fetal RHD typing result using DNA derived from maternal plasma from a solid organ transplant recipient. Transfusion 2006;46:1454-1455.)
55. Grill S, Banzola I, Li Y, Rekhviashvili T, Legler TJ, Müller SP, Zhong XY, Hahn S, Holzgreve W: High throughput non-invasive determination of foetal Rhesus D status using automated extraction of cell-free foetal DNA in maternal plasma and mass spec-trometry. Arch Gynecol Obstet 2009;279:533-537.
56. Machado IN, Castilho L, Pellegrino J Jr, Barini R: Fetal RhD genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras 2006;52:232-235.